Loading dose plus continuous/extended infusion versus intermittent bolus of β-lactams for the treatment of Gram-negative bacteria bloodstream infections: a …

DF Bavaro, A Belati, L Diella… - Journal of …, 2023 - academic.oup.com
Background Optimal β-lactam dosing for the treatment of Gram-negative bacteria
bloodstream infections (GNB-BSIs) remains a debated issue. Herein, the efficacy and safety …
被引用次数：3 相关文章

Loading dose plus continuous/extended infusion versus intermittent bolus of β-lactams for the treatment of Gram-negative bacteria bloodstream infections: a …

DF Bavaro, A Belati, L Diella, L Frallonardo, G Guido… - 2023 - cabidigitallibrary.org
Background: Optimal β-lactam dosing for the treatment of Gram-negative bacteria
bloodstream infections (GNB-BSIs) remains a debated issue. Herein, the efficacy and safety …

Loading dose plus continuous/extended infusion versus intermittent bolus of β-lactams for the treatment of Gram-negative bacteria bloodstream infections: a …

DF Bavaro, A Belati, L Diella… - The Journal of …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Optimal β-lactam dosing for the treatment of Gram-negative bacteria
bloodstream infections (GNB-BSIs) remains a debated issue. Herein, the efficacy and safety …

Loading dose plus continuous/extended infusion versus intermittent bolus of β-lactams for the treatment of Gram-negative bacteria bloodstream infections: a …

DF Bavaro, A Belati, L Diella… - Journal of …, 2023 - academic.oup.com
Background Optimal β-lactam dosing for the treatment of Gram-negative bacteria
bloodstream infections (GNB-BSIs) remains a debated issue. Herein, the efficacy and safety …

Loading dose plus continuous/extended infusion versus intermittent bolus of β-lactams for the treatment of Gram-negative bacteria bloodstream infections: a …

DF Bavaro, A Belati, L Diella, L Frallonardo… - The Journal of …, 2023 - europepmc.org
Background Optimal β-lactam dosing for the treatment of Gram-negative bacteria
bloodstream infections (GNB-BSIs) remains a debated issue. Herein, the efficacy and safety …